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High performance liquid chromatography (HPLC) is one of the most modern and widely used 
analytical  separation  methods.  Its  advantage  is  that  it  enables  qualitative  and  quantitative 
determination of substances even in a complex biological matrix.
Biocompatible iron chelators are used in therapy primarily for the treatment of iron overload. 
However, due to their antioxidant and antiproliferative effects, they could also find application in 
the treatment of other diseases (Parkinson's and Alzheimer's disease, cancer).
The  biocompatible  iron  chelator  salicylaldehyde  isonicotinoyl  hydrazone  (SIH)  from  the 
group of aroylhadrazones was very promising, with low toxicity and significant antioxidant and 
cytoprotective effect. However, its use is complicated by the short half-life in plasma. Therefore, 
chelators  were  derived  from its  structure  that are  expected  to  have  higher  stability.  The tested 
substances  were:  chloroacetophenone  isonicotinoyl  hydrazone  (CAF-INH)  and  hydroxymethyl 
acetophenone isonicotinoyl hydrazone (HMAF-INH).
The aim of this work was to develop optimal chromatographic conditions for HPLC analysis 
of these chelators and a sample treatment method in order to determine the analyte in a biological 
material.
The analysis was performed on a Merck 250x4 mm I. D. column packed with LiChrospher® 
100, RP-18e (5 μm) with a Purospher® 100, RP-18e (5 μm) precolumn.
For the analysis of the CAF-INH chelator in plasma, a mixture of phosphate buffer, methanol 
and acetonitrile, in a volume ratio of 40:30:30 (v / v / v), was selected as the mobile phase. The UV 
detector was set to wavelengths of 251 and 285 nm. For the HMAF-INH chelator, a mixture of 
phosphate buffer, methanol and acetonitrile in a volume ratio of 50:25:25 (v / v / v) was chosen as 
the mobile phase. The UV detector was set at 275 nm and 328 nm. The flow rate in both cases was 
1 ml / min. The retention time was 3.4 min for (Z) resp. 7.0 min for (E) CAF-INH isomer and 7.2 
min for HMAF-INH.
Precipitation deproteination with acetonitrile (0.4 ml to 0.2 ml plasma) was chosen for sample 
preparation, an extraction yield of 80% (CAF-INH), 93% (HMAF-INH) was achieved.
The  linearity  of  the  method  for  the  determination  of  both  analytes  was  verified  in  the 
concentration range of 10-100 µmol / l. The precision and accuracy of the method were verified for 
the determination of both substances in plasma and both validation parameters met the acceptance 
criteria for both analytes [12].
A 10-hour plasma stability study was performed. At its end, 40% CAF-INH and 47% HMAF-
INH remained. Both chelators thus proved to be significantly more stable than the parent compound 
SIH. The increased stability  may be due to an increase in the electron density on the carbonyl 
carbon and steric hindrance of the hydrazone bond.
